Hinge Health Reports Q3 2026 Financial Results and Updates Full-Year Guidance

Hinge Health reported third-quarter 2026 revenue of $235.0 million, above the $224.8 million FactSet consensus, and adjusted EPS of $0.71, exceeding the $0.58 estimate. The company raised its full-year 2026 revenue guidance to $879 million–$881 million, above the prior $860.6 million estimate, and forecast fourth-quarter revenue of $249 million–$251 million.